ÂÜÀòÂÒÂ×

Craig Taylor serves as the Senior Director of Business Operations & Development at Nouscom, a clinical-stage immuno-oncology company, since September 2024. Previously, Taylor held roles such as Senior Director of Strategic Operations at Tenpoint Therapeutics Ltd, and Director of Takeda ADT Operations following the acquisition of Adaptate Biotherapeutics. Taylor's extensive experience includes leadership positions at Adaptate, Virion Biotherapeutics, Congenica, and GfK Market Access. Early career roles included consulting and business development at F-star Biotechnology Ltd. and NanoString Technologies, where notable achievements included negotiations totaling $13 million and implementing quality systems to facilitate regulatory approval. Craig Taylor earned an MBA with a finance concentration from the University of Cambridge and a Bachelor of Science in Manufacturing and Supply Chain Management from Western Washington University.